A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial

Author： Pisano Carmela   Morabito Alessandro   Sorio Roberto   Breda Enrico   Lauria Rossella   Gebbia Vittorio   Scaltriti Laura   Scalone Simona   Zagonel Vittorina   Greggi Stefano   Beneduce Gerardo   Losito Simona   Gallo Ciro   Maio Massimo   Forestieri Valeria   Pignata Sandro  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.64, Iss.5, 2009-10, pp. : 1021-1027

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Altretamine (Hexamethylmelamine) in Platinum-Resistant and Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Phase II Trial

By Markman M.   Blessing J.A.   Moore D.   Ball H.   Lentz S.S.  

Gynecologic Oncology, Vol. 69, Iss. 3, 1998-06 ,pp. : 226-229

Elsevier

Access to resources Recommend Favorite

A phase II trial of capecitabine (Xeloda®) in recurrent ovarian cancer

By Miller Brigitte  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 29-30

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer

By Morgan Robert   Synold Timothy   Gandara David   Muggia Franco   Scudder Sidney   Reed Eddie   Margolin Kim   Raschko James   Leong Lucille   Shibata Stephen   Tetef Merry   Vasilev Steven   McGonigle Kathryn   Longmate Jeff   Yen Yun   Chow Warren   Somlo George   Carroll Mary   Doroshow James  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 4, 2004-10 ,pp. : 283-289

Springer Publishing Company

Access to resources Recommend Favorite

A phase II trial of ZD0473 in platinum-pretreated ovarian cancer

By Gore M.E.   Atkinson R.J.   Thomas H.   Cure H.   Rischin D.   Beale P.   Bougnoux P.   Dirix L.   Smit W.M.  

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2416-2420

Elsevier

Access to resources Recommend Favorite

Phase II Study of Gemcitabine and Docetaxel in Recurrent Platinum Resistant Ovarian Cancer

By Garcia Agustin A.   Yessaian Anne   Pham Huyen   Facio Grace   Muderspach Laila   Roman Lynda  

Cancer Investigation, Vol. 30, Iss. 4, 2012-04 ,pp. : 295-299

Informa Healthcare

Access to resources Recommend Favorite